JPMorgan Chase & Co’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.6K | Buy |
32,718
+32,672
| +71,026% | +$37.6K | ﹤0.01% | 5182 |
|
|
2025
Q1 | $69 | Sell |
46
-3
| -6% | -$5 | ﹤0.01% | 6046 |
|
|
2024
Q4 | $40 | Sell |
49
-2
| -4% | -$2 | ﹤0.01% | 6117 |
|
|
2024
Q3 | $42 | Buy |
51
+1
| +2% | +$1 | ﹤0.01% | 6077 |
|
|
2024
Q2 | $41 | Buy |
50
+16
| +47% | +$13 | ﹤0.01% | 6034 |
|
|
2024
Q1 | $28 | Sell |
34
-13
| -28% | -$11 | ﹤0.01% | 6110 |
|
|
2023
Q4 | $66 | Buy |
47
+34
| +262% | +$48 | ﹤0.01% | 6126 |
|
|
2023
Q3 | $15 | Buy |
+13
| New | +$15 | ﹤0.01% | 6269 |
|
|
2022
Q3 | – | Sell |
-566
| Closed | -$1K | – | 5695 |
|
|
2022
Q2 | $1K | Sell |
566
-1,801
| -76% | -$3.18K | ﹤0.01% | 5493 |
|
|
2022
Q1 | $8K | Sell |
2,367
-2,030
| -46% | -$6.86K | ﹤0.01% | 5428 |
|
|
2021
Q4 | $23K | Buy |
+4,397
| New | +$23K | ﹤0.01% | 5293 |
|